Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services.

	Three Months Ended June 30, 2020
	Life Sciences		Mobile Solutions		Power Solutions		Intersegment Sales Eliminations		Total
United States and Puerto Rico	$	60,027	$	20,237	$	30,859	$	(507)	$	110,616
China	2,716		10,726		1,252		—		14,694
Brazil	7		2,132		63		—		2,202
Mexico	6		2,456		4,119		—		6,581
Germany	4,986		851		90		—		5,927
Switzerland	2,590		618		2		—		3,210
Other	2,067		4,017		1,106		—		7,190
Total net sales	$	72,399	$	41,037	$	37,491	$	(507)	$	150,420

	Three Months Ended June 30, 2019
	Life Sciences		Mobile Solutions		Power Solutions		Intersegment Sales Eliminations		Total
United States and Puerto Rico	$	74,229	$	44,512	$	40,580	$	(503)	$	158,818
China	1,873		9,318		1,598		—		12,789
Brazil	—		9,636		80		—		9,716
Mexico	117		5,066		4,235		—		9,418
Germany	8,447		1,316		21		—		9,784
Switzerland	3,509		1,153		25		—		4,687
Other	3,157		8,443		4,854		—		16,454
Total net sales	$	91,332	$	79,444	$	51,393	$	(503)	$	221,666

	Six Months Ended June 30, 2020
	Life Sciences		Mobile Solutions		Power Solutions		Intersegment Sales Eliminations		Total
United States and Puerto Rico	$	130,389	$	57,366	$	69,156	$	(1,095)	$	255,816
China	4,754		18,418		2,409		—		25,581
Brazil	7		10,715		193		—		10,915
Mexico	126		7,292		6,262		—		13,680
Germany	10,596		3,001		129		—		13,726
Switzerland	5,622		1,549		23		—		7,194
Other	4,953		12,580		5,720		—		23,253
Total net sales	$	156,447	$	110,921	$	83,892	$	(1,095)	$	350,165

	Six Months Ended June 30, 2019
	Life Sciences		Mobile Solutions		Power Solutions		Intersegment Sales Eliminations		Total
United States and Puerto Rico	$	142,572	$	88,969	$	81,695	$	(987)	$	312,249
China	3,565		18,471		3,436		—		25,472
Brazil	—		18,018		149		—		18,167
Mexico	244		10,444		6,944		—		17,632
Germany	17,332		2,722		37		—		20,091
Switzerland	6,775		2,512		41		—		9,328
Other	6,852		16,383		8,748		—		31,983
Total net sales	$	177,340	$	157,519	$	101,050	$	(987)	$	434,922

Deferred Revenue

The following table provides information about contract liabilities from contracts with customers.

	Deferred Revenue
Balance at January 1, 2020	$	4,172
Balance at June 30, 2020	$	3,105

Revenue recognized during the six months ended June 30, 2020, from amounts included in deferred revenue at the beginning of the period for performance obligations satisfied or partially satisfied during the period, was $1.6 million. Deferred revenue is reported in the “Other current liabilities” line on the Condensed Consolidated Balance Sheets.

Transaction Price Allocated to Future Performance Obligations

We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of June 30, 2020, unless our contracts meet one of the practical expedients. Our contracts met the practical expedient for a performance obligation that is part of a contract that has an original expected duration of one year or less.

Sales Concentration

We recognized sales from a single customer of $20.0 million, or 13% of consolidated net sales, during the three months ended June 30, 2020, and $23.0 million, or 10% of consolidated net sales, during the three months ended June 30, 2019. We recognized sales from this customer of $45.5 million, or 13% of consolidated net sales, during the six months ended June 30, 2020, and $45.1 million, or 10% of consolidated net sales, during the six months ended June 30, 2019. Revenues from this customer are in our Life Sciences and Power Solutions groups.